The Oxford covid-19 vaccine candidate has produced promising early trial results

The news: A covid-19 vaccine candidate being developed by Oxford University and AstraZeneca proved safe and provoked a strong immune response in its first clinical trials. Participants’ systems produced both antibodies and T cells, and only relatively mild side effects were observed. The results were described today in a paper in The Lancet. The study:…
Read More

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: